DATA GRAPHICS | Regulation
Evkeeza for HoFH among April’s CHMP recommendations: Data Byte
April 23, 2021 11:21 PM UTC
April’s recommendations by EMA’s CHMP included a positive opinion for Evkeeza evinacumab from Regeneron to treat homozygous familial hypercholesterolemia, which offers a new mechanism of action to patients who don’t respond to statins or PCSK9 therapy.
FDA approved the ANGPTL3 inhibitor in February. ...